Interchange Capital Partners LLC Trims Stock Position in Medicus Pharma Ltd $MDCX

Interchange Capital Partners LLC lessened its holdings in shares of Medicus Pharma Ltd (NASDAQ:MDCX) by 4.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,586,871 shares of the company’s stock after selling 75,000 shares during the period. Medicus Pharma makes up 1.1% of Interchange Capital Partners LLC’s holdings, making the stock its 16th biggest position. Interchange Capital Partners LLC owned approximately 0.12% of Medicus Pharma worth $4,745,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in MDCX. SeaCrest Wealth Management LLC purchased a new position in Medicus Pharma in the second quarter valued at $139,000. Private Advisor Group LLC purchased a new position in Medicus Pharma in the first quarter valued at $211,000. Guyasuta Investment Advisors Inc. purchased a new position in Medicus Pharma in the second quarter valued at $230,000. Finally, Armistice Capital LLC purchased a new position in Medicus Pharma in the first quarter valued at $4,710,000.

Analyst Ratings Changes

A number of research analysts have weighed in on MDCX shares. D. Boral Capital reaffirmed a “buy” rating and issued a $27.00 price objective on shares of Medicus Pharma in a report on Wednesday. Zacks Research raised shares of Medicus Pharma to a “hold” rating in a report on Monday, September 15th. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Medicus Pharma in a research note on Saturday. Two investment analysts have rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $23.50.

Medicus Pharma Stock Up 11.1%

MDCX stock opened at $2.70 on Friday. The stock has a market capitalization of $48.11 million and a P/E ratio of -2.01. The firm has a 50-day simple moving average of $2.32 and a 200-day simple moving average of $3.14. Medicus Pharma Ltd has a 52 week low of $1.79 and a 52 week high of $8.94.

Medicus Pharma (NASDAQ:MDCX) last released its earnings results on Monday, August 11th. The company reported ($0.43) EPS for the quarter, missing analysts’ consensus estimates of ($0.39) by ($0.04). On average, analysts expect that Medicus Pharma Ltd will post -1.14 earnings per share for the current year.

About Medicus Pharma

Medicus Pharma Ltd is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Medicus Pharma Ltd is based in Toronto, Ontario.